Fairview Capital Investment Management’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.1M Buy
136,136
+54,199
+66% +$6.26M 0.85% 29
2026
Q1
$9.79M Buy
+81,937
New +$10.7M 0.53% 37

Other funds holding XYL

Fairview Capital Investment Management's XYL Position: Q2 2026 in Review

Fairview Capital Investment Management increased its Xylem (XYL) stake by 66% in Q2 2026, buying an estimated $6.26M and bringing the position to 136,136 shares worth $16.1M. The position accounts for 0.85% of the portfolio, ranked #29.

Fairview Capital Investment Management first reported a position in XYL in Q1 2026 and has held it in 2 quarters since. 1,093 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Fairview Capital Investment Management held 136,136 shares of Xylem worth $16.1M as of Q2 2026.
  • Fairview Capital Investment Management bought 54,199 Xylem shares in Q2 2026, an estimated $6.26M.
  • Xylem made up 0.85% of Fairview Capital Investment Management's portfolio in Q2 2026, its #29 holding.
  • Fairview Capital Investment Management first reported a position in Xylem in Q1 2026 and has held it in 2 quarters since.
  • 1,093 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Fairview Capital Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.